MCMedicalCodingSoftware
3E01329

3E01329Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduction of Oth Anti-infect into Subcu, Perc Approach

How 3E01329 is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. 3SectionAdministration — What family of procedure this is
  2. EBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. 1Body partThe specific site
  5. 3ApproachHow the site was reached
  6. 2DeviceWhat was left in place, if anything
  7. 9QualifierA further distinction where one applies

Codes near 3E01329

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • 3E00XKZIntroduction of Other Diagnostic Substance into Skin and Mucous Membranes, External Approach
  • 3E00XMZIntroduction of Pigment into Skin and Mucous Membranes, External Approach
  • 3E00XNZIntroduction of Analgesics, Hypnotics, Sedatives into Skin and Mucous Membranes, External Approach
  • 3E00XTZIntroduction of Destructive Agent into Skin and Mucous Membranes, External Approach
  • 3E0102AIntroduction of Anti-Infective Envelope into Subcutaneous Tissue, Open Approach
  • 3E01305Introduction of Other Antineoplastic into Subcutaneous Tissue, Percutaneous Approach
  • 3E0130MIntroduction of Antineoplastic, Monoclonal Antibody, into Subcutaneous Tissue, Percutaneous Approach
  • 3E01328Introduction of Oxazolidinones into Subcutaneous Tissue, Percutaneous Approach
  • 3E01329Introduction of Other Anti-infective into Subcutaneous Tissue, Percutaneous Approach
  • 3E0132AIntroduction of Anti-Infective Envelope into Subcutaneous Tissue, Percutaneous Approach
  • 3E0133ZIntroduction of Anti-inflammatory into Subcutaneous Tissue, Percutaneous Approach
  • 3E01340Introduction of Influenza Vaccine into Subcutaneous Tissue, Percutaneous Approach
  • 3E0134ZIntroduction of Serum, Toxoid and Vaccine into Subcutaneous Tissue, Percutaneous Approach
  • 3E0136ZIntroduction of Nutritional Substance into Subcutaneous Tissue, Percutaneous Approach
  • 3E0137ZIntroduction of Electrolytic and Water Balance Substance into Subcutaneous Tissue, Percutaneous Approach
  • 3E013BZIntroduction of Anesthetic Agent into Subcutaneous Tissue, Percutaneous Approach
  • 3E013GCIntroduction of Other Therapeutic Substance into Subcutaneous Tissue, Percutaneous Approach
ICD-10-PCSFY2026